Navigation Links
ARIUS Announces Third Quarter Fiscal 2007 Financial Results
Date:10/12/2007

d CD63 antibody program continues to produce results from further preclinical studies in a variety of cancer indications in its progress towards human clinical trials.

Takeda Collaboration

ARIUS successfully met its year one obligations and received all scheduled research payments from Takeda.

Additional Product Updates

Additionally, ARIUS continues to progress several other antibody candidates and has antibody programs targeting the MCSP antigen, AR005 antigen, and 37LRP in addition to several other undisclosed programs.

Management Change:

As part of its corporate governance review, ARIUS' Board of Directors has decided to nominate Mr. Carl Gordon as non-executive Chair of the Board of Directors. Dr. Young remains as President and Chief Executive Officer of the Company.

During the quarter, ARIUS' Executive Vice President and Chief Business Officer, Helen Findlay, left the Company to pursue other opportunities. In Ms. Findlay's role, she contributed to ARIUS' partnering and financing activities, helping to establish ARIUS on the path to becoming a clinical company.

Financial Results:

All amounts are in Canadian dollars unless otherwise indicated.

For the nine-month period ended August 31, 2007, the Company recorded a net loss of $8,104,701 ($0.18 per share) compared to a net loss of $2,820,462 ($0.09 per share) for the same period in fiscal 2006. The increase in net loss was the result of lower revenue, higher research and development expenses and higher general and administrative costs offset partially by lower interest expense and higher interest income. For the three-month period ended August 31, 2007, the Company recorded a net loss of $2,761,874 ($0.06 per share) compared to a net loss of $1,469,728 ($0.03 per share) for the three-month period ended August 31, 2006. This increase in net loss for the three-month period is primarily the result of higher research and development expenses, higher general
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , Dec. 24, ... a biopharmaceutical company advancing patient care in critical areas, ... 3,500,000 shares of common stock, and warrants to purchase ... at an offering price of $4.00 per share and ... exercise price of $5.00, are exercisable immediately, and expire ...
(Date:12/24/2014)... December 23, 2014 Earlier this year ... L. Sherley, director of the Adult Stem Cell Technology ... often overlooked and under appreciated unique property of adult ... Distributed Stem Cells: Misunderstood in the Past, Important for ... congress participants. He gave the address at the ...
(Date:12/24/2014)... 23, 2014 Nashville Fertility Center announced ... treasurer for the American Society for Reproductive Medicine (ASRM), ... research in reproductive medicine. In his new role ... the executive board and will have a voice in ... has actively supported ASRM since 1984 when he joined ...
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Dec. 22, 2010 Neogen Corporation (Nasdaq: ... 2nd Q Results WebcastWhen: , Tuesday, January 4, 2011 ... over the Internet -- Simply log on to the ... Maynard of Neogen Corporation, +1-800-234-5333.If you are unable to ...
... 21, 2010) -- A researcher known widely for ... use of minimally toxic, environmentally friendly chemicals will ... Dr. Paul Anastas, science advisor to the U.S. ... the EPA,s Office of Research and Development (ORD), ...
... YORK, Dec. 21, 2010 Reportlinker.com announces that ... its catalogue: Nanobiotechnologies- applications, markets ... SummaryNanotechnology is the creation and ... control of matter on the nanometer-length scale (a ...
Cached Biology Technology:Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations 2Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 2Reportlinker Adds Nanobiotechnologies- applications, markets and companies 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 4Reportlinker Adds Nanobiotechnologies- applications, markets and companies 5Reportlinker Adds Nanobiotechnologies- applications, markets and companies 6Reportlinker Adds Nanobiotechnologies- applications, markets and companies 7Reportlinker Adds Nanobiotechnologies- applications, markets and companies 8Reportlinker Adds Nanobiotechnologies- applications, markets and companies 9Reportlinker Adds Nanobiotechnologies- applications, markets and companies 10Reportlinker Adds Nanobiotechnologies- applications, markets and companies 11Reportlinker Adds Nanobiotechnologies- applications, markets and companies 12Reportlinker Adds Nanobiotechnologies- applications, markets and companies 13Reportlinker Adds Nanobiotechnologies- applications, markets and companies 14Reportlinker Adds Nanobiotechnologies- applications, markets and companies 15Reportlinker Adds Nanobiotechnologies- applications, markets and companies 16Reportlinker Adds Nanobiotechnologies- applications, markets and companies 17Reportlinker Adds Nanobiotechnologies- applications, markets and companies 18Reportlinker Adds Nanobiotechnologies- applications, markets and companies 19Reportlinker Adds Nanobiotechnologies- applications, markets and companies 20Reportlinker Adds Nanobiotechnologies- applications, markets and companies 21
(Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Curcumin, the major component in the spice turmeric, ... suppression of head and neck cancer cell growth, researchers ... naturally occurring spice widely used in South Asian and ... have medicinal properties, attributed to its anti-inflammatory effects. Previous ...
... cancer might soon be increased with a new vitamin E ... of Technology (QUT) prostate cancer researchers are leading the fight ... Dr Patrick Ling, whose research will be a centrepiece ... it opens in Brisbane, is leading a team of researchers ...
... Junction, NJ (October 19, 2010) Patients undergoing ... Inc.,s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a ... infection rate of 0.48% in the first 1.9 ... published results of TYRX,s COMMAND Clinical Study. There ...
Cached Biology News:Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 2Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 3Vitamin E in front line of prostate cancer fight 2Vitamin E in front line of prostate cancer fight 3TYRX AIGISRx antibacterial envelope shows low infection rate, high CIED procedure success 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
... been developed specifically for the stabilization ... microwell plates/strips. Coating Stabilizer maintains ... antibody or protein antigen portion of ... is filtered at 0.2 microns., ,Contents: ...
... Block is an anodized aluminum, solvent-resistant block ... to provide efficient thermal transfer to samples ... of the HT96 Isothermal Block replaces Cat. ... design allowing for compatibility with robotic applications. ...
Biology Products: